ProfileGDS5822 / ILMN_1233293
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 27% 78% 37% 77% 72% 84% 16% 44% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 114.627
GSM1276600PDAC Late Ablation Control 2123.478
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 115.237
GSM1276603PDAC Late Ablation 2117.677
GSM1276604PDAC Late Ablation 370.572
GSM1303940PDAC Late Ablation_anti-CTLA4 1229.384
GSM1303941PDAC Late Ablation_anti-CTLA4 29.316
GSM1303942PDAC Late Ablation_anti-CTLA4 321.844